Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 1/6 |
Dividends | 0/6 |
DBD Stock Overview
Diebold Nixdorf, Incorporated provides connected commerce solutions to financial institutions and retailers in Western Europe, Eastern Europe, Asia, the Middle East, Africa, the United States, Canada, Mexico, and Latin America.
Diebold Nixdorf, Incorporated Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$4.06 |
52 Week High | US$11.29 |
52 Week Low | US$2.12 |
Beta | 3.12 |
1 Month Change | 31.39% |
3 Month Change | 30.13% |
1 Year Change | -62.37% |
3 Year Change | -66.34% |
5 Year Change | -77.63% |
Change since IPO | -48.13% |
Recent News & Updates
Diebold Nixdorf slips as J.P. Morgan downgrades after 'low quality' Q2 report
Diebold Nixdorf (NYSE:DBD) shares fell nearly 5% in premarket trading on Friday as investment firm J.P. Morgan downgraded the financial technology company, noting its second-quarter results were "low quality." Analyst Paul Chung lowered his rating on Diebold (DBD) to underweight from neutral, noting that the company's management left its EBITDA and free cash flow guidance unchanged, despite the fact it lowered revenue guidance, citing "material" foreign exchange headwinds. "We see elevated risks to hitting guidance, in another heavily back end loaded year," Chung wrote in a note to clients. The analyst added that Diebold (DBD) is trading at a valuation to competitor NCR (NCR), despite lower operating profit margins, a more complex capital structure and "limited" free cash flow. Earlier this month, Diebold Nixdorf (DBD) rallied sharply despite the fact it lowered its revenue guidance for the full-year.
Diebold Nixdorf Q2 2022 Earnings Preview
Diebold Nixdorf (NYSE:DBD) is scheduled to announce Q2 earnings results on Tuesday, August 2nd, before market open. EPS Estimate is -$0.13 (-230.0% Y/Y) and the consensus Revenue Estimate is $886.96M (-6.0% Y/Y). has beaten EPS estimates 50% of the time and has beaten revenue estimates 50% of the time. upward revisions and 2 downward. Revenue estimates have seen 0 upward revisions and 5 downward.
Diebold Nixdorf (NYSE:DBD) Is Doing The Right Things To Multiply Its Share Price
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Shareholder Returns
DBD | US Tech | US Market | |
---|---|---|---|
7D | -2.9% | 5.0% | 4.5% |
1Y | -62.4% | 14.4% | -8.9% |
Return vs Industry: DBD underperformed the US Tech industry which returned 13.7% over the past year.
Return vs Market: DBD underperformed the US Market which returned -9.6% over the past year.
Price Volatility
DBD volatility | |
---|---|
DBD Average Weekly Movement | 15.5% |
Tech Industry Average Movement | 7.8% |
Market Average Movement | 7.6% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: DBD is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 15% a week.
Volatility Over Time: DBD's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1859 | 22,000 | Octavio Marquez | https://www.dieboldnixdorf.com |
Diebold Nixdorf, Incorporated provides connected commerce solutions to financial institutions and retailers in Western Europe, Eastern Europe, Asia, the Middle East, Africa, the United States, Canada, Mexico, and Latin America. It operates through Eurasia Banking, Americas Banking, and Retail segments. The company offers cash recyclers and dispensers, intelligent deposit terminals, teller automation tools, and kiosk technologies, as well as physical security solutions; and front-end applications for consumer connection points and back-end platforms that manage channel transactions, operations and integration, and facilitate omnichannel transactions, endpoint monitoring, remote asset management, customer marketing, merchandise management, and analytics.
Diebold Nixdorf, Incorporated Fundamentals Summary
DBD fundamental statistics | |
---|---|
Market Cap | US$320.61m |
Earnings (TTM) | -US$422.70m |
Revenue (TTM) | US$3.70b |
0.1x
P/S Ratio-0.8x
P/E RatioIs DBD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
DBD income statement (TTM) | |
---|---|
Revenue | US$3.70b |
Cost of Revenue | US$2.78b |
Gross Profit | US$915.60m |
Other Expenses | US$1.34b |
Earnings | -US$422.70m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | -5.35 |
Gross Margin | 24.75% |
Net Profit Margin | -11.43% |
Debt/Equity Ratio | -194.2% |
How did DBD perform over the long term?
See historical performance and comparison